Introduction: Food is not only a basic necessity for survival but also a key factor in maintaining health and well-being. In recent years, rapid population growth, climate change, urbanization, and ch ...

AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.

(NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Lee Cheng-hung, chairman of the Association of Taiwan Investment Enterprises on the Mainland, noted that the emphasis on high ...

No longer just about gentle and ‘clean’, the natural beauty sector is stepping into a new era ...

Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and extend runwaySAN ...

According to the Ministry of Science and Technology, national spending on R&D reached 2.8 percent of China’s GDP in 2025, while the value of technology contract transactions increased by 10.8 percent.

Explore how biopharmaceutical companies are navigating capital constraints, rising R&D costs, and regulatory demands amid ...

Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...

BioAtla, Inc. (NASDAQ: BCAB or the "Company"), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic ...